As someone who lives with the long-term effects of chikungunya, Camillo Mora PhD, sees the expanding habitat of mosquitos and is concerned more people will be exposed to vector-borne illnesses and deal with not only the acute phases of these viruses but also the possibility of long-term health effects they can present.
The European Commission has approved their first dengue vaccine, Takeda’s TAK-003, as climate change and urbanization contribute to a worldwide rise in dengue incidence.
As greenhouse gas emissions result in floods, heat waves, and more extreme weather events, people and pathogens are thrown closer together.
Investigators surmise a natural bat exposure within certain areas of the world may correspond with lower COVID-19 incidence rates.
Research shows specific climate elements affect mosquito proliferation and can play a role in predictors of vector activity and insect control interventions.
